Free Trial
→ Your $29.97 book is free today (From Profits Run) (Ad)tc pixel Free MIG3 Stock Alerts

Maven Income and Growth VCT 3 (MIG3) Competitors

Maven Income and Growth VCT 3 logo
GBX 42.80 -1.00 (-2.28%)
As of 04:39 AM Eastern
Compare

MIG3 vs. JMC, BIOG, STS, WPC, and JETI

Should you buy Maven Income and Growth VCT 3 stock or one of its competitors? MarketBeat compares Maven Income and Growth VCT 3 with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Maven Income and Growth VCT 3 include JP Morgan Chinese Investment Trust (JMC), The Biotech Growth Trust (BIOG), STS Global Income & Growth Trust (STS), Witan Pacific Investment Trust PLC (WPC.L) (WPC), and JPMorgan European Investment Trust Income Pool (JETI). These companies are all part of the "asset management" industry.

How does Maven Income and Growth VCT 3 compare to JP Morgan Chinese Investment Trust?

JP Morgan Chinese Investment Trust (LON:JMC) and Maven Income and Growth VCT 3 (LON:MIG3) are both small-cap asset management industry companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, risk, analyst recommendations, earnings, valuation, profitability and institutional ownership.

Maven Income and Growth VCT 3 has a net margin of 36.24% compared to JP Morgan Chinese Investment Trust's net margin of 0.00%. Maven Income and Growth VCT 3's return on equity of 1.83% beat JP Morgan Chinese Investment Trust's return on equity.

Company Net Margins Return on Equity Return on Assets
JP Morgan Chinese Investment TrustN/A N/A N/A
Maven Income and Growth VCT 3 36.24%1.83%-2.94%

In the previous week, Maven Income and Growth VCT 3 had 1 more articles in the media than JP Morgan Chinese Investment Trust. MarketBeat recorded 1 mentions for Maven Income and Growth VCT 3 and 0 mentions for JP Morgan Chinese Investment Trust. Maven Income and Growth VCT 3's average media sentiment score of 1.77 beat JP Morgan Chinese Investment Trust's score of 0.00 indicating that Maven Income and Growth VCT 3 is being referred to more favorably in the news media.

Company Overall Sentiment
JP Morgan Chinese Investment Trust Neutral
Maven Income and Growth VCT 3 Very Positive

JP Morgan Chinese Investment Trust pays an annual dividend of GBX 0.04 per share. Maven Income and Growth VCT 3 pays an annual dividend of GBX 4.15 per share and has a dividend yield of 9.7%. JP Morgan Chinese Investment Trust pays out -0.3% of its earnings in the form of a dividend. Maven Income and Growth VCT 3 pays out 456.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Maven Income and Growth VCT 3 has higher revenue and earnings than JP Morgan Chinese Investment Trust. JP Morgan Chinese Investment Trust is trading at a lower price-to-earnings ratio than Maven Income and Growth VCT 3, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
JP Morgan Chinese Investment Trust-£151K0.00N/A-£11.60N/A
Maven Income and Growth VCT 3£1.66M40.22£728.80K£0.9147.03

Summary

Maven Income and Growth VCT 3 beats JP Morgan Chinese Investment Trust on 8 of the 10 factors compared between the two stocks.

How does Maven Income and Growth VCT 3 compare to The Biotech Growth Trust?

Maven Income and Growth VCT 3 (LON:MIG3) and The Biotech Growth Trust (LON:BIOG) are both small-cap financial services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, media sentiment, institutional ownership, risk, valuation, dividends and profitability.

Maven Income and Growth VCT 3 has a beta of 0.13, indicating that its stock price is 87% less volatile than the broader market. Comparatively, The Biotech Growth Trust has a beta of 0.59097034, indicating that its stock price is 41% less volatile than the broader market.

5.5% of The Biotech Growth Trust shares are owned by institutional investors. 1.8% of Maven Income and Growth VCT 3 shares are owned by company insiders. Comparatively, 2.7% of The Biotech Growth Trust shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

The Biotech Growth Trust has a net margin of 140.73% compared to Maven Income and Growth VCT 3's net margin of 36.24%. Maven Income and Growth VCT 3's return on equity of 1.83% beat The Biotech Growth Trust's return on equity.

Company Net Margins Return on Equity Return on Assets
Maven Income and Growth VCT 336.24% 1.83% -2.94%
The Biotech Growth Trust 140.73%-8.91%12.39%

The Biotech Growth Trust has lower revenue, but higher earnings than Maven Income and Growth VCT 3. The Biotech Growth Trust is trading at a lower price-to-earnings ratio than Maven Income and Growth VCT 3, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Maven Income and Growth VCT 3£1.66M40.22£728.80K£0.9147.03
The Biotech Growth Trust-£17.73M-14.95£83.83M-£14.30N/A

In the previous week, Maven Income and Growth VCT 3 had 1 more articles in the media than The Biotech Growth Trust. MarketBeat recorded 1 mentions for Maven Income and Growth VCT 3 and 0 mentions for The Biotech Growth Trust. Maven Income and Growth VCT 3's average media sentiment score of 1.77 beat The Biotech Growth Trust's score of 0.00 indicating that Maven Income and Growth VCT 3 is being referred to more favorably in the media.

Company Overall Sentiment
Maven Income and Growth VCT 3 Very Positive
The Biotech Growth Trust Neutral

Summary

Maven Income and Growth VCT 3 beats The Biotech Growth Trust on 7 of the 13 factors compared between the two stocks.

How does Maven Income and Growth VCT 3 compare to STS Global Income & Growth Trust?

Maven Income and Growth VCT 3 (LON:MIG3) and STS Global Income & Growth Trust (LON:STS) are both small-cap financial services companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, earnings, media sentiment, institutional ownership, profitability and dividends.

Maven Income and Growth VCT 3 pays an annual dividend of GBX 4.15 per share and has a dividend yield of 9.7%. STS Global Income & Growth Trust pays an annual dividend of GBX 8.88 per share and has a dividend yield of 3.9%. Maven Income and Growth VCT 3 pays out 456.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. STS Global Income & Growth Trust pays out 44.8% of its earnings in the form of a dividend.

Maven Income and Growth VCT 3 has a beta of 0.13, suggesting that its share price is 87% less volatile than the broader market. Comparatively, STS Global Income & Growth Trust has a beta of 0.5437029, suggesting that its share price is 46% less volatile than the broader market.

STS Global Income & Growth Trust has higher revenue and earnings than Maven Income and Growth VCT 3. STS Global Income & Growth Trust is trading at a lower price-to-earnings ratio than Maven Income and Growth VCT 3, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Maven Income and Growth VCT 3£1.66M40.22£728.80K£0.9147.03
STS Global Income & Growth Trust£26.16M9.70£18.28M£19.8311.35

5.1% of STS Global Income & Growth Trust shares are held by institutional investors. 1.8% of Maven Income and Growth VCT 3 shares are held by insiders. Comparatively, 0.5% of STS Global Income & Growth Trust shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

STS Global Income & Growth Trust has a net margin of 87.12% compared to Maven Income and Growth VCT 3's net margin of 36.24%. STS Global Income & Growth Trust's return on equity of 8.55% beat Maven Income and Growth VCT 3's return on equity.

Company Net Margins Return on Equity Return on Assets
Maven Income and Growth VCT 336.24% 1.83% -2.94%
STS Global Income & Growth Trust 87.12%8.55%2.28%

In the previous week, STS Global Income & Growth Trust had 2 more articles in the media than Maven Income and Growth VCT 3. MarketBeat recorded 3 mentions for STS Global Income & Growth Trust and 1 mentions for Maven Income and Growth VCT 3. STS Global Income & Growth Trust's average media sentiment score of 1.89 beat Maven Income and Growth VCT 3's score of 1.77 indicating that STS Global Income & Growth Trust is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Maven Income and Growth VCT 3
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
STS Global Income & Growth Trust
3 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Summary

STS Global Income & Growth Trust beats Maven Income and Growth VCT 3 on 11 of the 15 factors compared between the two stocks.

How does Maven Income and Growth VCT 3 compare to Witan Pacific Investment Trust PLC (WPC.L)?

Maven Income and Growth VCT 3 (LON:MIG3) and Witan Pacific Investment Trust PLC (WPC.L) (LON:WPC) are both small-cap asset management industry companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, profitability, risk, valuation, earnings, analyst recommendations and media sentiment.

In the previous week, Maven Income and Growth VCT 3 had 1 more articles in the media than Witan Pacific Investment Trust PLC (WPC.L). MarketBeat recorded 1 mentions for Maven Income and Growth VCT 3 and 0 mentions for Witan Pacific Investment Trust PLC (WPC.L). Maven Income and Growth VCT 3's average media sentiment score of 1.77 beat Witan Pacific Investment Trust PLC (WPC.L)'s score of 0.00 indicating that Maven Income and Growth VCT 3 is being referred to more favorably in the media.

Company Overall Sentiment
Maven Income and Growth VCT 3 Very Positive
Witan Pacific Investment Trust PLC (WPC.L) Neutral

Maven Income and Growth VCT 3 pays an annual dividend of GBX 4.15 per share and has a dividend yield of 9.7%. Witan Pacific Investment Trust PLC (WPC.L) pays an annual dividend of GBX 0.05 per share. Maven Income and Growth VCT 3 pays out 456.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Witan Pacific Investment Trust PLC (WPC.L) pays out 0.9% of its earnings in the form of a dividend.

Maven Income and Growth VCT 3 has a net margin of 36.24% compared to Witan Pacific Investment Trust PLC (WPC.L)'s net margin of 0.00%. Maven Income and Growth VCT 3's return on equity of 1.83% beat Witan Pacific Investment Trust PLC (WPC.L)'s return on equity.

Company Net Margins Return on Equity Return on Assets
Maven Income and Growth VCT 336.24% 1.83% -2.94%
Witan Pacific Investment Trust PLC (WPC.L) N/A N/A N/A

Maven Income and Growth VCT 3 has higher earnings, but lower revenue than Witan Pacific Investment Trust PLC (WPC.L). Witan Pacific Investment Trust PLC (WPC.L) is trading at a lower price-to-earnings ratio than Maven Income and Growth VCT 3, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Maven Income and Growth VCT 3£1.66M40.22£728.80K£0.9147.03
Witan Pacific Investment Trust PLC (WPC.L)£6.74M0.00N/A£5.70N/A

Summary

Maven Income and Growth VCT 3 and Witan Pacific Investment Trust PLC (WPC.L) tied by winning 5 of the 10 factors compared between the two stocks.

How does Maven Income and Growth VCT 3 compare to JPMorgan European Investment Trust Income Pool?

JPMorgan European Investment Trust Income Pool (LON:JETI) and Maven Income and Growth VCT 3 (LON:MIG3) are both small-cap asset management industry companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, media sentiment, earnings, valuation, risk and analyst recommendations.

Maven Income and Growth VCT 3 has higher revenue and earnings than JPMorgan European Investment Trust Income Pool. JPMorgan European Investment Trust Income Pool is trading at a lower price-to-earnings ratio than Maven Income and Growth VCT 3, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
JPMorgan European Investment Trust Income PoolN/AN/AN/A£67.80N/A
Maven Income and Growth VCT 3£1.66M40.22£728.80K£0.9147.03

In the previous week, Maven Income and Growth VCT 3 had 1 more articles in the media than JPMorgan European Investment Trust Income Pool. MarketBeat recorded 1 mentions for Maven Income and Growth VCT 3 and 0 mentions for JPMorgan European Investment Trust Income Pool. Maven Income and Growth VCT 3's average media sentiment score of 1.77 beat JPMorgan European Investment Trust Income Pool's score of 0.00 indicating that Maven Income and Growth VCT 3 is being referred to more favorably in the news media.

Company Overall Sentiment
JPMorgan European Investment Trust Income Pool Neutral
Maven Income and Growth VCT 3 Very Positive

Maven Income and Growth VCT 3 has a net margin of 36.24% compared to JPMorgan European Investment Trust Income Pool's net margin of 0.00%. Maven Income and Growth VCT 3's return on equity of 1.83% beat JPMorgan European Investment Trust Income Pool's return on equity.

Company Net Margins Return on Equity Return on Assets
JPMorgan European Investment Trust Income PoolN/A N/A N/A
Maven Income and Growth VCT 3 36.24%1.83%-2.94%

JPMorgan European Investment Trust Income Pool pays an annual dividend of GBX 0.07 per share. Maven Income and Growth VCT 3 pays an annual dividend of GBX 4.15 per share and has a dividend yield of 9.7%. JPMorgan European Investment Trust Income Pool pays out 0.1% of its earnings in the form of a dividend. Maven Income and Growth VCT 3 pays out 456.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Summary

Maven Income and Growth VCT 3 beats JPMorgan European Investment Trust Income Pool on 7 of the 10 factors compared between the two stocks.

Get Maven Income and Growth VCT 3 News Delivered to You Automatically

Sign up to receive the latest news and ratings for MIG3 and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MIG3 vs. The Competition

Export
MetricMaven Income and Growth VCT 3Asset Management IndustryFinancial SectorLON Exchange
Market Cap£66.88M£2.38B£5.76B£2.79B
Dividend Yield3.65%5.99%5.27%6.09%
P/E Ratio47.0325.2215.78366.15
Price / Sales40.221,964.78933.9688,429.84
Price / Cash2.7660.1790.3227.89
Price / Book0.801.354.407.74
Net Income£728.80K£265.53M£1.15B£5.89B
7 Day Performance-1.83%-0.12%0.40%0.82%
1 Month Performance-5.73%2.40%2.24%2.78%
1 Year Performance-5.73%13.44%21.88%87.90%

Maven Income and Growth VCT 3 Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MIG3
Maven Income and Growth VCT 3
N/AGBX 42.80
-2.3%		N/AN/A£66.88M£1.66M47.03N/A
JMC
JP Morgan Chinese Investment Trust
N/AN/AN/AN/A£255.55M-£151KN/AN/A
BIOG
The Biotech Growth Trust
N/AGBX 1,275.06
-2.2%		N/A+93.5%£254.11M-£17.73MN/AN/A
STS
STS Global Income & Growth Trust
N/AGBX 221
flat		N/A-6.3%£252.07M£26.16M11.146
WPC
Witan Pacific Investment Trust PLC (WPC.L)
N/AN/AN/AN/A£242.69M£6.74M69.65190

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:MIG3) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners
Before you buy SpaceX shares, consider this alternative approach
SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...
Weiss Ratings | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
NNVC FDA = New Momentum Wave!
NanoViricides (NYSE: NNVC) just received FDA Orphan Drug Designation for its antiviral NV-387, targeting measl...
Equiscreen | Sponsoredtc pixel
Peptide Company Lands Exclusive MMA Wellness Partnership
A publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform t...
The Tomorrow Investor | Sponsoredtc pixel
This is the worst news for stocks in 50 years
Goldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...
TradeSmith | Sponsoredtc pixel
The system holding the dollar together is gone…
Saudi Arabia has terminated its 1974 petrodollar agreement with the United States - the deal that forced every...
Golden Portfolio | Sponsoredtc pixel
Millionaire warns: Move your money before May 15
Larry Benedict - the trader who generated $274 million in client profits and beat the S&P 500 by 18 times in 2...
Brownstone Research | Sponsoredtc pixel